As of Jul 31
| +0.15 / +2.35%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 19.88, with a high estimate of 25.00 and a low estimate of 11.50. The median estimate represents a +204.36% increase from the last price of 6.53.
The current consensus among 4 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.